(Q39643947)
English
N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a novel metabotropic glutamate 2 potentiator with potential anxiolytic/antidepressant properties: in vivo profiling suggests a lin
scientific article published on 14 October 2010
Statements
N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a novel metabotropic glutamate 2 potentiator with potential anxiolytic/antidepressant properties: in vivo profiling suggests a link between behavioral and central nervous system neurochemical changes (English)
Matthew J Fell
Jeffrey M Witkin
Julie F Falcone
Jason S Katner
Kenneth W Perry
John Hart
Linda Rorick-Kehn
Carl D Overshiner
Kurt Rasmussen
Stephen F Chaney
Mark J Benvenga
Xia Li
Deanna L Marlow
Linda K Thompson
Susan K Luecke
Keith A Wafford
Dale M Edgar
Anne T Quets
Christian C Felder
XuShan Wang
Beverly A Heinz
Alexander Nikolayev
Ming-Shang Kuo
Daniel Mayhugh
Albert Khilevich
Deyi Zhang
James A Eckstein
Bradley L Ackermann
Steven P Swanson
John T Catlow
Robert A Dean
Kimberley Jackson
Sitra Tauscher-Wisniewski
Gerard J Marek
Jeffrey M Schkeryantz
Kjell A Svensson
14 October 2010